PROVECTUS BIOPHARMACEUTICALS, INC. 4
4 · PROVECTUS BIOPHARMACEUTICALS, INC. · Filed Oct 7, 2014
Insider Transaction Report
Form 4
DEES H CRAIG
DirectorChief Executive Officer
Transactions
- Other
Stock Option (right to buy)
2014-10-03−475,000→ 475,000 totalExercise: $0.93From: 2011-09-06Exp: 2021-09-06→ Common Stock (475,000 underlying) - Other
Stock Option (right to buy)
2014-10-03−475,000→ 475,000 totalExercise: $1.00From: 2010-07-22Exp: 2020-07-22→ Common Stock (475,000 underlying)
Footnotes (1)
- [F1]On October 3, 2014, the Reporting Person entered into a rescission agreement with the Issuer for the cancellation of 50% of (i) options to purchase 950,000 shares of the Issuer's common stock granted to the Reporting Person on September 6, 2011 and (ii) options to purchase 950,000 shares of the Issuer's common stock granted to the Reporting Person on July 22, 2010.